-+ 0.00%
-+ 0.00%
-+ 0.00%

Touyun Biotech Clarifies Share Options Require Minimum 12-Month Vesting Period

PUBT·11/17/2026 09:36:06
Touyun Biotech Clarifies Share Options Require Minimum 12-Month Vesting Period
  • Touyun Biotech clarified its 2025 annual report, disclosing unlisted equity investments of approximately HK$ 181.2 million at December 31.
  • Unlisted holdings increased approximately HK$ 85.3 million, reflecting improved investee financial performance and new acquisitions.
  • Listed equity investments totaled approximately HK$ 97.8 million, up approximately HK$ 46.6 million, mainly on higher share prices.
  • The share option scheme requires a minimum 12-month vesting period; it expires June 13, 2035, unless terminated early.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Touyun Biotech Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261117-12415768), on November 17, 2026, and is solely responsible for the information contained therein.